[ad_1] Biocon Ltd on Monday said its arm Biocon Pharma Ltd has received approval from the US health regulator for its generic version of Everolimus tablets for oral suspension used in the treatment of tuberous sclerosis complex, a rare genetic disease that causes non-cancerous tumors or lesions in different parts of the body. The approval…
[ad_1] New Delhi: Drug maker Lupin on Friday said it has received approval from the US health regulator to market a generic drug for the treatment of multiple sclerosis. The company has received tentative approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application for Siponimod Tablets in strengths of…
[ad_1] Cipla, Hetero win bid to supply widely prescribed diabetes drug in China We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] Alembic Pharmaceuticals Ltd on Friday said it has received final approval from the US health regulator for its generic version of Dasatinib tablets used to treat certain types of blood cancer. The approval by the US Food & Drug Administration (USFDA) is for the abbreviated new drug application (ANDA) of Dasatinib Tablets of strengths…
[ad_1] Natco Pharma on Wednesday said it has launched a generic medication to treat high blood pressure in the lungs in the US with 180-day exclusivity. The company has launched Bosentan tablets for oral suspension (32 mg), a generic version of Tracleer tablets by Actelion Pharmaceuticals US Inc. Natco’s marketing partner for the product is…